Effectiveness of metformin prescription practices guideline to prevent metformin associated lactic acidosis in a diabetic patient at the Somdejphrajoataksin Maharaj Hospital

Authors

  • Sitthi Fakthongyoo Somdejphrajoataksin Maharaj Hospital

Keywords:

metformin, lactic acidosis, metabolic acidosis, rational drug use, practice guideline, metformin prescription

Abstract

Objective: To study the effectiveness of metformin prescription practices guideline to prevent metformin associated lactic acidosis (MALA) in diabetic patients at Somdejphrajoataksin Maharaj Hospital

Methodology: This study was an interrupt time study that selected all type 2 diabetes patients receiving metformin from the outpatient department of the Somdejphrajoataksin Maharaj Hospital from January 1, 2023 to December 31, 2023. The research tools were metformin prescription practices to prevent MALA, compilation of data using medication error record form, drug-related adverse events record form. Data was analyzed by frequency, percentage, and Chi’s square test.

Results: The studies were 3,671 patients.  Before using the metformin prescription practices guideline there were 1,654 unreasonably prescriptions (13.75%) and after using the guideline, there were 109 unreasonably prescriptions (0.82%), that was a significantly reduced unreasonably prescriptions (p=0.001). Incidence of MALA after using the guideline was significantly lower than before using the guideline (p = 0.002). There were 30 (0.89%) MALA incidents and reduced to 12 (0.33%) after using the guideline.

Conclusion: The metformin prescription practices guideline can reduce the number of prescriptions that were unreasonably prescribed, as well as statistically significantly reduce the incidence of MALA occurrences.

References

UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overnight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-65. doi: https://doi.org/10.1016/S0140-6736(98)07037-8.

The Royal College of Physicians of Thailand, Diabetes Association of Thailand, The endrocrine society of Thailand, Department of Medical Services and National Health Security Office. Clinical Practice Guideline for Diabetics 2023. Bangkok: Srimuang Printing co.,Ltd; 2023. [In Thai]

Triplitt CL, Reasner CA, Isley WL. Diabetes mellitus. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, et al, editors. Pharmacotherapy a pathophysiologic approach. 7th ed. New York: The McGraw-Hill; 2008. p. 1205-41.

Office of the Permanent Secretary Ministry of Public Health. Service plan: Rational Drug Use; RDU. Bangkok: Ministry of Public Health; 2559 [In Thai]

DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism. 2016;65(2):20-9. doi: 10.1016/j.metabol.2015.10.014.

van Berlo-van de Laar IR, Vermeij CG, Doorenbos CJ. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. J Clin Pharm Ther. 2011;36(3):376-82. doi: 10.1111/j.1365-2710.2010.01192.x.

Lalau JD, Kajbaf F, Bennis Y, Hurtel-Lemaire AS, Belpaire F, De Broe ME. Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4. Diabetes Care. 2018;41(3):547-53. doi: 10.2337/dc17-2231.

U.S. Food and Drug Administration. FDA drug safety communication: FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function [Internet]. United States: U.S. Food and Drug Administration; c2023. [updated 2017 Nov 14; cited 2023 dec 8]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-revises-warnings-regarding-use-diabetes-medicine-metformin-certain

Medical Record and Statistics division, Somdejprajoataksin Maharaj hospital. The Patients record 2020-2023. Tak: Somdejprajoataksin Maharaj hospital; 2023. [In Thai]

Ponhiamhan S. The effectiveness of using the protocol for monitoring incidence of Metformin Associated Lactic Acidosis in diabetic mellitus patients at Nakhonphanom Hospital. Nakhonphanom Hospital Journal. 2021;8(1):52-62. [In Thai]

Kobpungton P, Chueamuangphan N. Association factors of metformin associated lactic acidosis in diabetic patient at Chiangrai Prachanukroh hospital. Chiang Rai Medical Journal. 2020;12(1):44-51. [In Thai]

Downloads

Published

04-11-2024

How to Cite

Fakthongyoo, S. (2024). Effectiveness of metformin prescription practices guideline to prevent metformin associated lactic acidosis in a diabetic patient at the Somdejphrajoataksin Maharaj Hospital. Journal of Nakornping Hospital, 15(2), 336–348. Retrieved from https://he01.tci-thaijo.org/index.php/jnkp/article/view/271017

Issue

Section

Research article